Titelmasterformat durch Klicken bearbeiten
Torsten C. Schmidt, Holger Lutze
POTENTIAL AND LIMITATIONS OF
(ADVANCED) OXIDATION PROCESSES
IN WATER AND WASTEWATER
TREATMENT
Cairo, February 19, 2013
Outline
Introduction/Overview of Oxidative Processes
Examples of our Recent Work:
Lab Scale: Mechanistic Investigations with
Probe Compounds:
Degradation of Micropollutants
Pilot Scale: Implementation of Ozonation in
Drinking Water Treatment
(Full Scale: Advanced Treatment of
Wastewater Effluents)
Conclusions and Outlook
Use of Oxidation Processes in Water
Treatment
Advantages:
• Constant process performance
• No disposal of concentrates or solids
(compared with AC sorption or membrane filtration)
Areas of Use:
• Drinking water
– Disinfection, Decolorization, Fe(II) and Mn(II) Removal, Micropollutant Elimination
• Municipal wastewater
– Disinfection, Further elimination of micropollutants
• Industrial wastewater
• High purity industrial process waters
Important Considerations in Oxidative
Treatment Processes
Pollutants
Oxidation CO2, H2OLifetime
Mechanisms
Kinetics
Transformation products
Biodegradability D Toxicological effects
Scavenging by matrix components
Possible loss of efficiency, Oxidation byproducts
Prediction of
elimination based on properties
possible?
Oxidation
Modified after U. von Gunten, eawag
Energy Demand/Carbon Footprint?
Estrogen Receptor
Effect?
Effect
Oxidation
Estrogenically active compound
Effect of Oxidative Transformation:
Reduction of Estrogenicity
Transformation product
binds?
binds
Modified after U. von Gunten, eawag
17b-Estradiole (E2)
Reduction of estrogenicity is proportional to concentration decline of EE2
Lee et al. 2008
Reduction of Estrogenic Effects (EEEQ) of 17a-
Ethinylestradiole by Oxidative Processes
dose, M
0 5 10 15 20 25 30
Relative EE2 or EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
Relative EE2
0.0 0.2 0.4 0.6 0.8 1.0
Relative EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
Chlorine
dose, M
0 5 10 15 20 25 30
Bromine
Relative EE2
0.0 0.2 0.4 0.6 0.8 1.0
Relative EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
dose, M
0 5 10 15 20 25 30
Ozone
Relative EE2
0.0 0.2 0.4 0.6 0.8 1.0
Relative EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
UV fluence, mJ/cm2
0 100 200 300 400
0.0 0.2 0.4 0.6 0.8 1.0
OH radical
Relative EE2
0.0 0.2 0.4 0.6 0.8 1.0
Relative EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
dose, M
0 5 10 15 20 25 30
Chlorine dioxide
Relative EE2
0.0 0.2 0.4 0.6 0.8 1.0
Relative EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
dose, M
0 10 20 30 40
Ferrate
Relative EE2
0.0 0.2 0.4 0.6 0.8 1.0
Relative EEEQ
0.0 0.2 0.4 0.6 0.8 1.0
1
r2 = 0.96 r2 = 0.99
1 1
r2 = 0.99
1 r2 = 0.99
1 r2 = 0.99
1 r2 = 0.99
Relative EE2 or EEEQ
EE2 EEEQ
Modified after U. von Gunten, eawag
17a-Ethinylestradiole (EE2)
Oxidation + Biological Filtration:
Reduction of Toxic Effects in Whole Effluents
• Data from WWTP Regensdorf, CH:
Adapted from S. Zimmermann, EPFL
Elimination by ozonation and slow sand filtration in % Bioluminescence
suppression
Acetylcholinesterase suppression
Algae test
(photosynthesis) Algae test
(growth) YES Assay
Overview Advanced Oxidation Processes
UV based Ozone based H2O2 based
UV/H2O2
UV/O3
O3/H2O2
No Chemicals
O3/AC Ozonation
Fenton Ultrasound
UV/TiO2
H2O+Ultrasound OH +H H2O + VUV(120-160nm) OH +H
2O3 + HO2- 2OH +3O2 O3 + AC OH + O2 O3 + (OH-, NOM) OH H2O2 + UVC 2 OH (F = 1)
O3+UVC H2O2 OH+O2
TiO2 + hn h+ + e- OH + O2-
Vacuum UV (VUV)
OH- yield: 50%
[Jarocki et al., in prep.]
H2O2
Fe(II) Fe(III)
OH
H2O2 HO2
[Fe(III)HO2]2+
Also direct photolysis
pH < 4
BrO3- NDMA
Comparison of Advanced Oxidative
Processes
UV based Ozone based H2O2 based
UV/H2O2(TiO2) UV/O3
O3/H2O2 No Chemicals
O3/AC Ozonation
Fenton Ultrasound
Energy demand
Vacuum UV
Loss of oxidation efficiency via matrix scavenging, assimilable organic carbon formation, unknown transformation products
Negative Effects
Br- HOBr/OBr-
BrO3- O3
O3/•OH H2O2
Br-
Describing Pollutant Removal
Oxidant
No. of publ.
kinetic const.
k (ca. 2008)
Ozone ~ 500
OH Radicals ~ 2000 Chlorine ~ 300 Chlorodioxide ~ 100 Ferrate(VI) ~ 50
)
d P k ox P
dt =
)
0
ln P
k ox t
P =
Typical second order kinetic constants for a pollutant P:
pH, T!
Quantification oxidant exposure:
• Matrix dependent
• Dosage dependent
• Consideration of secondary oxidants Determination kinetic constants:
• Direct measurements
• Indirect measurements (Competition kinetics)
• Quantitative structure activity relationships (QSARs)
• Estimation from similar oxidants
Modified after U. von Gunten, eawag
Mechanistic Investigations
Degradation of Micropollutants:
Example Diclofenac
N
HOOC Cl
Cl H
O3
N
HOOC Cl
Cl H
O3
Possible sites of ozone attack
Diclofenac
(Non-Steroidal Anti-
Inflammatory Drug)
Ref.: Sein et al. (2008), Environ. Sci. Technol. 42, 6656
Degradation of Micropollutants:
Example Diclofenac
Ref.: Sein et al. (2008), Environ. Sci. Technol. 42, 6656 CH2
C
O OH
N
Cl
Cl H
O O
O CH2
C
O OH
N
Cl
Cl H
O
3CH2 O C OH
N
Cl
Cl
- O3
- H+
.
O
3 + H
2O
OH + O
2+ OH
([Diclofenac]0 = 50 µM) ■ Diclofenac
■ Iminoquinone (major intermediate) ■ 2,6-Dichloroaniline
0 5 10 15 20 25 30 35 40 45 50
0 50 100 150 200 250
[Ozone] / µM
[Diclofenac] and [Products] / µM
N
O
Cl
Cl CH2
COOH
Ref.: Sein et al. (2008), Environ. Sci. Technol. 42, 6656
Diclofenac Degradation in Presence of t-BuOH
Suggested Reaction Mechanism for the
Formation of the Iminoquinone Intermediate
CH2 N
Cl
Cl
.
CO2H
O3 / - O2
CH2 N
Cl
.
ClCO2H
O H
CH2 N
Cl
Cl
.
CO2H
HO
CH2 N
Cl
.
ClCO2H
O2
HO O O - HO2
CH2 N
Cl
Cl CO2H
O
1,2 H-shift
Iminoquinone
Ref.: Sein et al. (2008), Environ. Sci. Technol. 42, 6656
Pilot-Scale Study
• Provides drinking water for ca. 80% of the population of Luxemburg
• The drinking water treatment plant was build up in 1969
• Modernization of treatment and increase of water production to 100’000 m3/d
planned
SEBES
Surface area: 3,8 km2 Capacity: 60 Mill. m3
SEBES Syndicat des Eaux du Barrage
d'Esch-sur-Sûre
Raw Water
Postozonation
pH Adjustment/Flocculation
Membrane Filtration
Preozonation
pH Adjustment/Flocculation
Membrane Filtration
Biological Filtration
Simplified Scheme of the Pilot Plant
Pilot Study SEBES
Accompanying Lab Studies:
Ozone Scavenging
Ozone half life time vs. ozone dose preozonation (RW O3), postozonation (UF O3) and AOP O3/H2O2 (UF AOP)
206
402
573
701
26
230 260
523
63 57 58 46
0 100 200 300 400 500 600 700 800
1 2 3 5
t[s]
c(O3) [mg/l]
RW O3 UF O3 UF AOP
0 0,005 0,01 0,015 0,02 0,025 0,03
1 2 3 4 5
Ozone exposure [M×s]
c(O3) [mg/L]
RW O3 UF O3 UF AOP
Accompanying Lab Studies:
Disinfection Efficiency
Ozone exposure vs. ozone dose; preozonation (RW O3), postozonation (UF O3) and AOP O3/H2O2 (UF AOP); reaction time 500 s, DOC: raw water 2 mg/L, UF filtrate 1 mg/L, alkalinity: 0.4 mM, pH: 7
99% inactivation B. subtilis spores
Accompanying Lab Studies:
Bromate Formation Potential
Bromate formation vs. ozone dose, c(Br-): 20 µg/L, complete ozone depletion, preozonation (RW O3), postozonation (UF O3) and AOP O3/H2O2 (UF AOP), DOC: RW 2 mg/L, UF 1 mg/L,
Alkalinity: 0.4 mM, pH: 7
Bromate TLV
0 5 10 15 20 25
1 2 3 5
c(BrO3- )[µg/l]
c(O3) [mg/l]
RW O3
UF O3
UF AOP Bromate drinking water
standard
Design of Postozonation
Design of Postozonation
PN 2
PN 3
PN 1
H
2O
2Q = 1 m
3/h
c(O
3) = 1, 3, 5 mg/L
c(H
2O
2) = ca. c(O
3)
Reaction time = 10 min
0 10 20 30 40 50 60 70 80 90 100
Raw water Flocculation/UF UF O3 AC filter
Residual conc. in %
Pilot: Micropollutant Elimination
Bentazone MTBE
Dichlorobenzamide
Diclofenac Carbamazepine
Sulfadiazine
Ozon dose UF O3 1mg/L O3, PN 3
kO3: < 10, 700, > 103 M-1s-1
Pilot: Micropollutant Elimination
0 0,2 0,4 0,6 0,8 1 1,2
1 2 3 4
Concentration [µg/l]
Sampling point
No transformation of Chlorthalonil M12 by O3 or •OH
S O
O
OH
N H2
O
Cl
Cl Cl
N
PN1 PN2 PN3 Complete ozone
consumption
AOP O3/H2O2 , O3 4 mg/L, H2O2 17 mg/L DOC 1 mg/L, Alkalinity:
0.4 mM, pH: 7
Summary of Pilot Study
(Preozonation)
Intermediate disinfection
Intermediate oxidation efficiency
Bromate formation at high ozone doses
O
3Flocculation + UF
O
3(Postozonation)
Good disinfection
Lowered oxidation efficiency
Increased bromate formation
O
3+ H
2O
2(Post AOP)
Poor disinfection
High oxidation efficiency
Bromate formation can be controlled
Reservoir
Synergy via switch between two modi
Disinfection modus Oxidation modus
Full-Scale Implementation
45
Elimination of pharmaceutical residues in
municipal wastewater treatment plants
(WWTP: Schwerte, Bad Sassendorf & Duisburg-Vierlinden)
Institut für
Siedlungswasserwirtschaft und Abfalltechnik
Lehrstuhl für Siedlungswasser- wirtschaft und Umwelttechnik
Abteilung für Hygiene, Sozial- und Umweltmedizin
Project management: Dr. Thomas Grünebaum (Ruhrverband, Essen)
Research projects „Reine Ruhr“
Final report :
http://www.lanuv.nrw.de/wasser/abwasser/forschung/abwa
sser.htm
Elimination of Selected Target Compounds in
Large Scale WWTP
2 mg Ozone/L, zspec = 0.36
0 10 20 30 40 50 60 70 80 90 100
Elimination [%]
n.d.
© Jochen Türk, IUTA
0 10 20 30 40 50 60 70 80 90 100
Elimination [%]
5 mg Ozone/L, zspec = 0.91
Take-home Messages
Oxidative Processes can be used to meet (additional)
goals of water and wastewater treatment
Optimized technical use requires a profound
understanding of chemistry of oxidant species
including formation of oxidation byproducts
For micropollutant elimination detailed knowledge of
transformation reaction is needed but enormous
effort needed
Comprehensive economical and effect-orientied
evaluations are still largely lacking
Acknowledgements
• Current and Previous Coworkers in Oxidative Processes:
Alexandra Jarocki, Alexandra Beermann, Maike Cyris, Agnes Tekle- Rötering, Sebastian Kowal, Alaa Salma, Myint Sein, Clemens von Sonntag, Jochen Türk, numerous students
• Collaborators:
Urs von Gunten, Georges Kraus, Jean-Paul Lickes, Stefan Panglisch, André Tatzel
• Funding:
Deutsche Forschungsgemeinschaft, BMWi/AiF, BMBF, Deutsche
Bundesstiftung Umwelt, Wasserchemische Gesellschaft, EU MC-ITN ATWARM
ANAKON 2011, Zürich Wasser 2012, Neu-Ulm